Related content

A simplified analysis of [F]3′-deoxy-3′-fluorothymidine metabolism and retention

By Shields Anthony   Briston David   Chandupatla Samatha   Douglas Kirk   Lawhorn-Crews Jawana   Collins Jerry   Mangner Thomas   Heilbrun Lance   Muzik Otto  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 32, Iss. 11, 2005-11 ,pp. : 1269-1275

Springer Publishing Company

Access to resources Recommend Favorite

Is 3′-deoxy-3′-¹⁸F-fluorothymidine a better marker for tumour response than ¹⁸F-fluorodeoxyglucose?

By Reske Sven   Deisenhofer Sandra  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 1, 2006-07 ,pp. : 38-43

Springer Publishing Company

Access to resources Recommend Favorite

Positron Emission Tomography with [ 18 F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study

By Dehdashti Farrokh  

Molecular Imaging and Biology, Vol. 15, Iss. 1, 2013-02 ,pp. : 106-113

Springer Publishing Company

Access to resources Recommend Favorite

Letter to the Editor re: Positron Emission Tomography with [¹⁸F]-3′-Deoxy-3′fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: a Pilot Study

By Chalkidou A.   Mikhaeel G.   O’Doherty M.   Marsden P.  

Molecular Imaging and Biology, Vol. 15, Iss. 5, 2013-10 ,pp. : 521-522

Springer Publishing Company

Access to resources Recommend Favorite

Response to the Letter to the Editor Regarding the Manuscript Entitled “Positron Emission Tomography with [¹⁸F]-3′-Deoxy-3′Fluorothymidine (FLT) as a Predictor of Outcome in Patients with Locally Advanced Resectable Rectal Cancer: A Pilot Study”

By Dehdashti Farrokh   Grigsby Perry   Siegel Barry  

Molecular Imaging and Biology, Vol. 15, Iss. 6, 2013-12 ,pp. : 786-787

Springer Publishing Company

Access to resources Recommend Favorite